Breakdown | TTM | Dec 2025 | Dec 2023 | Dec 2023 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 4.02B | 4.02B | 2.79B | 3.32B | 2.47B | 2.39B |
Gross Profit | 2.13B | 2.13B | 1.45B | 1.82B | 1.35B | 1.18B |
EBITDA | 1.91B | 1.55B | 1.37B | 1.59B | 1.07B | 1.27B |
Net Income | 1.37B | 1.37B | 835.29M | 1.01B | 751.08M | 895.16M |
Balance Sheet | ||||||
Total Assets | 9.58B | 9.58B | 7.70B | 8.42B | 7.27B | 6.72B |
Cash, Cash Equivalents and Short-Term Investments | 6.47B | 6.47B | 5.65B | 6.23B | 5.22B | 4.86B |
Total Debt | 237.69M | 237.69M | 174.78M | 195.54M | 89.13M | 72.26M |
Total Liabilities | 1.42B | 1.42B | 905.77M | 1.17B | 745.98M | 787.34M |
Stockholders Equity | 8.06B | 8.06B | 6.72B | 7.17B | 6.47B | 5.89B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.08B | 707.36M | 817.10M | 490.20M | 816.84M |
Operating Cash Flow | 0.00 | 1.23B | 822.42M | 908.82M | 680.03M | 861.74M |
Investing Cash Flow | 0.00 | -584.28M | 128.80M | -390.66M | -273.18M | -377.19M |
Financing Cash Flow | 0.00 | -539.96M | -633.31M | -629.55M | -351.38M | -433.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ₹62.31B | 35.10 | 16.14% | 0.93% | 10.80% | 21.15% | |
67 Neutral | ₹338.99B | 46.58 | 26.67% | 1.25% | 6.03% | 11.92% | |
66 Neutral | ₹46.70B | 32.74 | ― | 1.16% | 21.24% | 36.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
CARE Ratings Limited has announced the transfer of equity shares to the Investor Education and Protection Fund Authority, as required by the Companies Act, 2013. This move, communicated through newspaper advertisements and letters to shareholders, reflects the company’s compliance with regulatory obligations, potentially impacting shareholder dynamics and reinforcing its commitment to governance standards.
CARE Ratings Limited has announced the allotment of 16,066 equity shares to its employees under the CARE Employee Stock Option Scheme 2020, following approval by the Nomination and Remuneration Committee. This allotment will increase the company’s paid-up share capital, reflecting its commitment to employee engagement and retention through stock-based incentives.